Medicare Enrolled
Brent Calhoon, PA-C
Medical Physician Assistant · Reading, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Calhoon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Calhoon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Calhoon
Brent Calhoon is a medical physician assistant in Reading, PA, with 20 years of NPI registration. Based on federal Medicare data, Calhoon performed 16,592 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Calhoon received a total of $10,940 from 72 pharmaceutical and/or device companies across 507 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Calhoon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 0% volume in PA
$10,940 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗16,592
Medicare services
Top 0% in PA for medical physician assistant
Not available
Unique patients (not deduplicated)
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 7,740 | $18 | $31 |
| Leuprolide injectable, camcevi, 1 mg | 6,510 | $67 | $177 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
911 | $54 | $139 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
414 | $2 | $15 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
206 | $21 | $115 |
| Injection, triptorelin pamoate, 3.75 mg | 162 | $289 | $500 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
144 | $8 | $41 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
122 | $9 | $47 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
109 | $73 | $315 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
87 | $3 | $20 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
70 | $69 | $210 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
41 | $48 | $476 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
41 | $77 | $210 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
35 | $35 | $249 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,940
Total received (2021-2024)
Avg $2,735/year across 4 years
Top 2% in PA for medical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
507
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,929
2023
$2,617
2022
$2,690
2021
$2,704
Payments by company (2024)
Dendreon Pharmaceuticals LLC
$324
Teleflex LLC
$320
Sumitomo Pharma America, Inc.
$288
Bayer Healthcare Pharmaceuticals Inc.
$254
PFIZER INC.
$227
AstraZeneca Pharmaceuticals LP
$137
Janssen Biotech, Inc.
$134
Merck Sharp & Dohme LLC
$131
Myriad Genetic Laboratories, Inc.
$126
UROGEN PHARMA, INC.
$123
Axonics, Inc.
$105
ABBVIE INC.
$105
SUN PHARMACEUTICAL INDUSTRIES INC.
$102
Antares Pharma, Inc.
$96
PROGENICS PHARMACEUTICALS, INC.
$72
Novartis Pharmaceuticals Corporation
$68
180 Medical, Inc.
$56
Tolmar, Inc.
$41
Telix Pharmaceuticals
$39
Ferring Pharmaceuticals Inc.
$38
BLUEWIND MEDICAL
$32
Novo Nordisk Inc
$25
Ambu Inc.
$24
Tempus AI, Inc
$23
COLOPLAST CORP
$21
Verity Pharmaceuticals Inc.
$17
Top 3 companies account for 31.8% of 2024 payments
All-time payments by company (2021-2024) ›
Dendreon Pharmaceuticals LLC
$1,544
PFIZER INC.
$657
Teleflex LLC
$575
Sumitomo Pharma America, Inc.
$535
Bayer Healthcare Pharmaceuticals Inc.
$461
AstraZeneca Pharmaceuticals LP
$450
Amgen Inc.
$423
Astellas Pharma US Inc
$396
Myriad Genetic Laboratories, Inc.
$347
Bayer HealthCare Pharmaceuticals Inc.
$326
Merck Sharp & Dohme LLC
$315
Biohaven Pharmaceuticals, Inc.
$280
Boehringer Ingelheim Pharmaceuticals, Inc.
$258
AbbVie Inc.
$249
Janssen Biotech, Inc.
$245
UROVANT SCIENCES INC
$206
Novartis Pharmaceuticals Corporation
$186
Amarin Pharma Inc.
$186
Antares Pharma, Inc.
$169
Esperion Therapeutics, Inc.
$157
Novo Nordisk Inc
$155
Foundation Medicine, Inc.
$149
180 Medical, Inc.
$140
UroGen Pharma, Inc.
$132
Biohaven Pharmaceutical Holding Company Ltd.
$124
UROGEN PHARMA, INC.
$123
Axonics, Inc.
$120
ABBVIE INC.
$105
SANOFI-AVENTIS U.S. LLC
$105
SUN PHARMACEUTICAL INDUSTRIES INC.
$102
Progenics Pharmaceuticals, Inc.
$102
Supernus Pharmaceuticals, Inc.
$94
Tolmar, Inc.
$87
ConvaTec Inc.
$78
PROGENICS PHARMACEUTICALS, INC.
$72
TOLMAR Pharmaceuticals, Inc.
$71
Teva Pharmaceuticals USA, Inc.
$67
Verity Pharmaceuticals Inc.
$67
Telix Pharmaceuticals
$66
Myovant Sciences Inc.
$65
Merck Sharp & Dohme Corporation
$63
Medtronic, Inc.
$59
GlaxoSmithKline, LLC.
$53
Lilly USA, LLC
$50
Paratek Pharmaceuticals, Inc.
$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$45
Agiliti Surgical, Inc.
$44
Blue Earth Diagnostics Limited
$44
Kowa Pharmaceuticals America, Inc.
$41
Ferring Pharmaceuticals Inc.
$38
Laborie Medical Technologies Corp.
$36
Sun Pharmaceutical Industries Inc.
$35
Lundbeck LLC
$34
BLUEWIND MEDICAL
$32
Accord Healthcare, Inc.
$27
Otsuka America Pharmaceutical, Inc.
$26
Ambu Inc.
$24
Tempus AI, Inc
$23
Eisai Inc.
$22
COLOPLAST CORP
$21
MannKind Corporation
$20
Clarus Therapeutics Inc.
$19
PROCEPT BioRobotics Corporation
$18
ABC Home Medical Supply, Inc.
$18
Alexion Pharmaceuticals, Inc.
$18
Bausch Health US, LLC
$16
Sunovion Pharmaceuticals Inc.
$16
Amneal Pharmaceuticals LLC
$14
Biogen, Inc.
$14
Coloplast Corp
$13
Currax Pharmaceuticals LLC
$12
Abbott Laboratories
$12
Top 3 companies account for 25.4% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AFREZZA · AJOVY · ANORO ELLIPTA · APLENZIN · AQUABEAM ROBOTIC SYSTEM · AUSTEDO · Aimovig · Axonics · Axumin · BELSOMRA · BOTOX · BREZTRI · CAMCEVI · CONTRAVE · Dayvigo · ELIGARD · ELIQUIS · EMGALITY · ENTRESTO · ERLEADA · EVENITY · FARXIGA · FOUNDATIONONE · FreeStyle Libre 2 · GARDASIL 9 · GEMTESA · GENTLECATH · ILLUCCIX · INTELLIS · JARDIANCE · JATENZO · JELMYTO · KEYTRUDA · Kerendia · LINZESS · LYNPARZA · Livalo · Luja Coude · MYRBETRIQ · Myrbetriq · NEXLETOL · NEXLIZET · NOCDURNA · NURTEC ODT · NUZYRA · Nubeqa · ORGOVYX · Otezla · Ozempic · PLUVICTO · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · QULIPTA · REVI · REXULTI · RYBELSUS · Repatha · SOLIQUA 100/33 · STIOLTO RESPIMAT · SYNTHROID · Saxenda · Seglentis · Sonablate · SpeediCath · Strensiq · TLANDO · TRELEGY ELLIPTA · TRULICITY · Trelstar · UBRELVY · UROLIFT · VRAYLAR · Vascepa · Wegovy · XGEVA · XIFAXAN · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZOMIG
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical physician assistants in nearby ZIP areas
268
County median income
$77,684
Nearest hospital to ZIP centroid (approximate)
READING HOSPITAL
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Calhoon is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Calhoon experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Calhoon performed 7,740 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Calhoon receive payments from pharmaceutical companies?
Yes. Calhoon received a total of $10,940 from 72 companies across 507 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Calhoon's costs compare to other medical physician assistants in Reading?
Calhoon's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Calhoon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Physician Assistants in Reading
Browse medical physician assistants in Reading ranked by procedure volume and transparency data.
Highest volume
Top Medical Physician Assistants in PA
Medical physician assistants ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Physician Assistants in PA
Which PA medical physician assistants receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology